The University of California, Davis, reached a major milestone attracting $1.07 billion in external research funding in the fiscal year 2021-22, up $102.9 million from the previous record set last year. In doing so, UC Davis joins an exclusive group of fewer than 20 public universities in the nation surpassing $1 billion in research funding.
The awards lend support to a wide range of research areas including advancing public health and medicine, developing new technologies in food, agriculture and the environment, empowering the underserved and enabling a more resilient society.
This new record for research award funding marks a historic moment for UC Davis, said Chancellor Gary S. May. More than ever, our university is on a mission to address some of the worlds greatest challenges, from how we feed the world to the health of all living beings. This milestone shows clearly how UC Davis research is being sought more than ever, by both the public and private sector, and across numerous fields. Im confident this kind of global impact from UC Davis will only continue to grow.
A primary contributor to this years growth came from funding within the College of Agricultural and Environmental Sciences, up by $72 million from the previous year for a total of $225 million. The School of Medicine also noticed a large increase, adding $29 million for a total of $396 million. The School of Veterinary Medicine ($89 million), College of Engineering ($79 million) and College of Biological Sciences ($68 million) rounded out the top five.
The federal government remained the largest provider of funding at $499 million, although down by $15 million from last year. The second leading source was the state of California at $210 million, up by $46 million from the previous year. Funding from industry made up the third highest source, totaling $104 million. Substantial increases also came from charities (up $26 million) and other UC programs (up $29 million).
As the funding for research grows, so does the impact that UC Davis extends around the world, said Prasant Mohapatra, vice chancellor for research at UC Davis. This years grand accomplishment of surpassing $1 billion in research funding will translate into tomorrows discoveries, insight and products that offer a brighter future for our global community.
An event to celebrate the achievement and showcase some of the exciting research discoveries and emerging technologies is planned for this fall. You can sign up to register for the event here.
The largest award, $53.4 million from the USDA Food and Nutrition Service, went to Kamaljeet Khaira, director of the University of California CalFresh Nutrition Education Program (UC CalFresh) to help reduce the chronic rate of obesity and encourage the awareness of healthy foods and increased physical activity among low-income individuals.
The goal of the GEMINI: GxExM Innovation in Intelligence for climate adaptation project is to use 3D modeling, artificial intelligence and crop genetics to develop new technologies to improve and accelerate breeding pipelines for common bean, cowpea and sorghum, which are key crops for food and income for smallholder farmers in sub-Saharan Africa. The project is co-led by Christine Diepenbrock and Brian Bailey, assistant professors in the Department of Plant Sciences, and Mason Earles, assistant professor in the Department of Biological and Agricultural Engineering, and funded by the Bill & Melinda Gates Foundation.
This research project aims to integrate molecular and cellular physiology measurements on single neurons in order to identify how disease-causing genetic mutations alter neuron behaviors. Gerald Quon, an assistant professor in the Department of Molecular and Cellular Biology and the Genome Center, is leading the project that is funded by the National Institutes of Health (NIH).
The goal of the alternative COVID-19 antigen production project is to explore the viability of a range of biomanufacturing technologies to produce antigens using six different systems: two plants, and cultured mammalian, bacterial, yeast and filamentous fungal cells. The two-year project is led by Karen McDonald, a professor in the Department of Chemical Engineering, and funded by the National Institute of Standards and Technologies (NIST) through the Bioindustrial Manufacturing and Design Ecosystem (BioMADE),
The psychedelics research project led by David Olson, an associate professor in the departments of Chemistry and Biochemistry and Molecular Medicine, plans to screen hundreds of compounds to discover new, nonhallucinogenic treatments for substance use disorders. Funded by the National Institute on Drug Abuse, part of the National Institutes of Health, the study will help us understand the basic mechanisms by which these compounds impact addiction and may help development of more effective and better tolerated treatments.
The two projects from UC Davis Continuing and Professional Education Human Services are focused on supporting the delivery of training and workforce development services for public child welfare agencies and community-based organizations providing intensive services to vulnerable children, youth and families throughout California. Funded by the California Department of Social Services, the programs include instruction and development of new courses and training programs to meet evolving needs of the states child- and family-serving agencies. The projects are led by program directors Alison Book and Nancy Hafer.
The Blackstone Charitable Foundation project supports the creation of entrepreneurs and innovators under the name "Blackstone LaunchPad with a focus on entrepreneurial skill-building so students can succeed in any career they choose. The UC Davis Blackstone LaunchPad makes progress towards specific milestones of increasing cumulative UC Davis student participation each year to support their skills in moving from ideas to growth to ultimately positive impact through a variety of on- and off-campus activities. The project is led by Andrew Hargadon, a professor and Soderquist Chair in Entrepreneurship in the Graduate School of Management (administered by the Mike and Renee Child Institute for Innovation and Entrepreneurship) and sponsored by Hanumantha Unnava, dean of the school.
The project titled Examining how teacher-student interactions within mathematics and literacy instructional contexts relate to the developmental and academic outcomes of early elementary students with autism proposes to bridge the gap between autism research and general education practices. The project is led by Nicole Sparapani, an associate professor in the School of Education and the MIND Institute, along with co-principal investigators Professor Peter Mundy and Nancy Tseng, lecturer in the UC Davis School of Education. Funded by the Institute of Education Sciences, the team will explore how general education teachers can use inclusive math and literacy instructional practices to support learners with autism in their kindergarten to third grade general education classrooms in large, diverse public school districts in Northern California.
The goal of this project from the School of Law is to provide legal services without charge to indigent persons, particularly client groups that have traditionally lacked significant legal representation including migrants, survivors of domestic violence and individuals whose civil rights have been violated. It is led by Gabriel Chin, professor of law and director of Clinical Legal Education, and funded by the State Bar of California.
This research project will examine hospital-to-home transitions for older adult couples who are managing heart failure. The ultimate goal is to develop interventions to support better symptom response and management during these transitions. The project is led by Julie T. Bidwell, an assistant professor in the Family Caregiving Institute at the Betty Irene Moore School of Nursing, and supported by the National Institutes of Health and National Institute of Nursing Research.
This project aims to improve breast cancer, heart health and Alzheimers disease care for women. The Krueger v. Wyeth Settlement Funds award will enable UC Davis Health researchers to study health disparities and advance projects focused on women of color and those in underserved communities. These women are traditionally underrepresented in research and have unique disease risks. As program director, Angela Haczku, a professor of medicine and associate dean of research at the School of Medicine, is assisting principal investigators Professor Luis Carvajal-Carmona, Professor Diana Miglioretti, Professor Amparo Villablanca and Professor Rachel Whitmer, School of Medicine leading the work in the four major projects of this collaborative research award.
Through a project funded by the National Science Foundation titled Impacts of rapid landscape change and biodiversity on virus host specificity, the researchers plan to investigate emerging and re-emerging viruses in transitional ecosystems where landscape change is most likely to influence disease transmission from wildlife to humans. The project is led by Christine Johnson, professor of epidemiology and ecosystem health in the UC Davis School of Veterinary Medicine and Assistant Researcher Tierra Smiley Evans (EpiCenter for Disease Dynamics, One Health Institute), Professor Lark Coffey (Department of Pathology, Microbiology and Immunology, UC Davis School of Veterinary Medicine), Rebekah Kading (Colorado State University), Mike Boots (UC Berkeley), and Ohnmar Aung and Pyae Phyo Aung (Nature Conservation Society - Myanmar).
Interdisciplinary research conducted by Organized Research Units, Special Research Programs, and IMPACT Centerswithin the Office of Research continued to attract significant funding at $113 million, up 19% from last year.** These joint efforts often focus on addressing complex, large-scale challenges that require expertise from many perspectives. Notable examples include:
The UC Davis Energy and Efficiency Institute, as a sub-awardee from Lawrence Berkeley Laboratory, will establish the California Flexible Load Research and Deployment Hub to conduct electricity sector applied research and development and technology demonstration and deployment projects. The goal of the project is to reduce dependence on fossil generation, firm up renewable resources to help California achieve its renewable generation and decarbonization goals. The principal investigator at UC Davis is Professor John Kissock, Department of Mechanical and Aerospace Engineering. The project is funded by the California Energy Commission.
The goal ofthis projectis to identify treatments and develop therapeutics to stop Alzheimers disease from causing irreversible damage to the brain.John H Morrison, professor in the Department of Neurology and director of the California National Primate Research Center, and his team are developing nonhuman primate models of Alzheimers disease that could explain the biochemical and cellular basis of neurodegeneration associated with the disease, and provide new therapeutic targets.This project was funded through theNational Institute on Aging(NIA).
This cooperative effort between the National Park Service and the Air Quality Research Center(AQRC)at UC Davis will analyze data and develop new methods and approaches to enhance the quality and scope of monitoringparticulate matter andvisibility in national parks, wilderness areas, wildlife refuges and other protected areas designated by Congress. The project is an enhancement to the Interagency Monitoring of Protected Visual Environments (IMPROVE) network,which is operated by the AQRC at UC Davis,and is led by AnnM.Dillner, associate director of analytical research, with funding from theU.S. National Park Service and support from the U.S. Environmental Protection Agency.
Note: Reports are based on the principal investigators home school or college. Where funds are awarded up-front to cover several years, the money is counted in the first year the award was received. Incrementally funded awards are counted as authorized in each year.
*Project funding allocated in fiscal year 2019, but active in fiscal year 2022.
**Interdisciplinary totals reported by principal investigators administrative unit
See the rest here:
UC Davis Sets a New Record, Surpasses $1 Billion in Research Funding - University of California, Davis
- Exercise promotes a molecular profile in muscle: Research - January 21st, 2023
- Molecular Diagnostics Laboratory < Laboratory Medicine - January 4th, 2023
- Molecular cloning - Wikipedia - December 18th, 2022
- Trends in Molecular Medicine | Journal - ScienceDirect - December 10th, 2022
- Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravel molecular secrets hidden in premature aging diseases... - December 2nd, 2022
- Nuclear Medicine and Molecular Imaging Week: October 2-8, 2022 - October 29th, 2022
- Biochemistry & Molecular Biology | Medicine - October 29th, 2022
- Cellular and Molecular Medicine | Faculty of Medicine - October 21st, 2022
- Molecular Diagnostics > Fact Sheets > Yale Medicine - October 21st, 2022
- Expert Reviews in Molecular Medicine | Cambridge Core - October 13th, 2022
- UT Southwestern ranked top health care institution globally for published research by Nature Index - UT Southwestern - October 13th, 2022
- Common Antibiotics Are Losing Their Potency. Researchers Pinpoint Mechanism to Restore It. - NYU Langone Health - October 13th, 2022
- expert reaction to study looking at integrating human stem cell-derived brain-like tissue in the brains of newborn rats - Science Media Centre - October 13th, 2022
- HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery - Yahoo Finance - October 13th, 2022
- UVA Discovers Key Driver of High Blood Pressure - UVA Health Newsroom - October 13th, 2022
- Postdoctoral Fellow in Lung Cancer Genomics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311727 - Times Higher Education - October 13th, 2022
- Common cold may increase the risk of long Covid - Earth.com - October 13th, 2022
- Caris' Precision Oncology Alliance Welcomes The Cancer Institute at The University of Tennessee Medical Center - PR Newswire - October 13th, 2022
- Merus Announces Publication of Abstract on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics - Yahoo... - October 13th, 2022
- Molecular Test Could Improve Early Detection of Pancreatic Cancer - Technology Networks - October 13th, 2022
- UTSW researchers identify key player in cellular response to stress - EurekAlert - October 4th, 2022
- New Antibody Demonstrates Therapeutic Benefits Against Alzheimers - SciTechDaily - October 4th, 2022
- Mount Sinai study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention - EurekAlert - October 4th, 2022
- NovoPath Pushes the Limits of Laboratory Information Systems with Integrated Workflows for Genetic and Molecular Testing - PR Newswire - October 4th, 2022
- Postdoctoral Fellow in Bioinformatics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311073 - Times Higher Education - October 4th, 2022
- Breast Cancer Awareness | Nick Jacobs | An unlikely partnership: The United States Army Space and Missile Defense Command and the Joyce Murtha Breast... - October 4th, 2022
- Tackling resistance to HIF2 drugs with an RNA-based therapy - UT Southwestern - October 4th, 2022
- OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an adjunct to Cytoreductive Surgery of Peritoneal Carcinomatosis - Business... - October 4th, 2022
- SIMATS organizes Induction Ceremony - Afternoonnews - Afternoon News - October 4th, 2022
- ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology - Yale School of Medicine - September 25th, 2022
- Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes - Business Wire - September 25th, 2022
- New Startups Built From UC Davis Innovations Drive Solutions in Food, Health and Agriculture - University of California, Davis - September 25th, 2022
- Scientists Discover New Cancer Treatment - The Morning News - September 25th, 2022
- Rewriting the Textbook for Precision Medicine - Technology Networks - September 25th, 2022
- Biden says 'The pandemic is over,' but health experts disagree - Chief Healthcare Executive - September 25th, 2022
- Discovery Illuminates How Parkinson's Disease Spreads in The Brain - Weill Cornell Medicine Newsroom - September 25th, 2022
- AI Used to Determine Cause of Alzheimer's and Related Disorders - Inside Precision Medicine - September 25th, 2022
- Looking Ahead in the Treatment of Breast Cancer - Targeted Oncology - September 25th, 2022
- Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children - EurekAlert - September 25th, 2022
- New study reveals breakthrough infections increase immunity to COVID-19 - OHSU News - September 25th, 2022
- Coronavirus Today: Who's dying of COVID-19 now? - Los Angeles Times - September 25th, 2022
- Hoag Named Radiopharmaceutical Therapy Center of Excellence, Publishes Results of Breast and Prostate Cancer Trials - PR Newswire - September 8th, 2022
- Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines - Yahoo Finance - September 8th, 2022
- Scientists urged the Biden administration to launch an Operation Warp Speed to develop inhaled COVID vaccines. China beat the U.S. to the punch -... - September 8th, 2022
- Foundation Medicine to Share 14 Abstracts at the 2022 European Society for Medical Oncology (ESMO) Congress Demonstrating the Power of Genomic... - September 8th, 2022
- Monte Rosa Therapeutics Announces FDA Clearance of Investigational New Drug Application for MRT-2359, a GSPT1-directed Molecular Glue Degrader Phase... - September 8th, 2022
- Biden administration says the once-a-year shot phase of the COVID-19 pandemic has arrived - The Boston Globe - September 8th, 2022
- ICCBS welcomes students of MPhil and PhD Programs 2022 - The Academia Mag - September 8th, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 308114 - Times... - September 8th, 2022
- Congratulations to our NRF award winners | UCT News - University of Cape Town News - September 8th, 2022
- Patients with some forms of aggressive esophageal cancers may benefit from treatment targeting how cells self-regulate - EurekAlert - September 8th, 2022
- Molecular Medicine (M.Sc.) - Georg-August-Universitt Gttingen - August 30th, 2022
- Gradalis Announces Publication in Nature Communications Medicine Identifying Survival Predicting Biomarker in Patients with Ovarian Cancer Treated... - August 30th, 2022
- Feinstein Institutes Get $3M From Lupus Research Alliance to Study Remission and Future Therapies - Business Wire - August 30th, 2022
- Unlocking the Power of Precision Medicine the Rheumatology Example - Technology Networks - August 30th, 2022
- When to trust your covid test results and when to question them | Mint - Mint - August 30th, 2022
- Molecular Diagnostics Market Report 2022-2030: Increasing Adoption of Point-Of-Care (Poc) Testing and the Development of Novel Assays Presents... - August 30th, 2022
- Advancing Precision Oncology, Ochsner Health First to Fully Integrate with Tempus and Epic's Genomics Module - Newswise - August 30th, 2022
- Tiny, Touch-Based Sensor Could Help Patients Stay on Top of Their Medications - SciTechDaily - August 30th, 2022
- Stellar Scholars Join CLAS Faculty - UConn Today - University of Connecticut - August 30th, 2022
- COVID-19 gave new urgency to the science of restoring smell - Science News Magazine - August 30th, 2022
- Dr. Sun lab wins R01 from National Institutes of Health to study liver proteins - Wayne State University - August 22nd, 2022
- Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference - GlobeNewswire - August 22nd, 2022
- New Study Identifies How A Group Of Genes Are Linked To Behavioral Conditions - Forbes - August 22nd, 2022
- New gene variant that protects against coronary heart disease uncovered - EurekAlert - August 22nd, 2022
- How a Japanese Herbal Medicine Protects the Gut Against Inflammatory Bowel Disease - Neuroscience News - August 22nd, 2022
- Insilico Medicine presents on AI for drug discovery at 9th Annual Aging Research and Drug Discovery Conference - EurekAlert - August 22nd, 2022
- Why polio is back on the radar of Canadian health officials - Brighter World - August 22nd, 2022
- Angela DeMichele, MD, MSCE, Assesses the Value of I-SPY2 for Neoadjuvant Treatment of Early Breast Cancer - Cancer Network - August 22nd, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 304753 - Times... - August 22nd, 2022
- Sensor could help patients stay on top of their meds - EurekAlert - August 22nd, 2022
- Trivitron Healthcare launches CoE in metabolomics, genomics, newborn screening and molecular diagnostics - Express Healthcare - August 22nd, 2022
- Research Trends of Moxibustion Therapy for Pain Treatment Over the Pas | JPR - Dove Medical Press - August 22nd, 2022
- Edited Transcript of EXAI.OQ earnings conference call or presentation 18-Aug-22 12:30pm GMT - Yahoo Finance - August 22nd, 2022
- Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75 - PR Newswire - August 22nd, 2022
- Will Omicron BA.5 Be the Last of the COVID Variants? - The Epoch Times - August 22nd, 2022
- Many Paths to Failure | Harvard Medical School - Harvard Medical School - August 5th, 2022
- Mitochondrial DNA Mutations Linked to Heart Disease Risk - University of California San Diego - August 5th, 2022
- A first update on mapping the human genetic architecture of COVID-19 - Nature.com - August 5th, 2022
- Summer Scholars leave Duke with a once-in-a-lifetime research experience - Duke University - August 5th, 2022